LICENSING PROCEEDS DISTRIBUTION AGREEMENTLicensing Proceeds Distribution Agreement • October 17th, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations
This Agreement (the “Agreement”), entered into this 15th day of February, 2022 (‘‘the “Effective Date”), by and between GRDG Sciences, LLC, a Florida company with a business address at 234 W. Central Ave., Winter Haven, Florida 33880 (hereinafter “GRDG”), and collectively, Global BioLife, Inc. (hereinafter “Global”), Impact BioLife Sciences, Inc. to include Impact Biomedical Inc. (hereinafter “Impact”), each a Nevada corporation with a business address at 701 S Carson Street, Suite 200, Carson City, Nevada 89701, collectively referred to as the “Parties” or individually as a ‘‘Party’’.
LICENSING PROCEEDS DISTRIBUTION AGREEMENTLicensing Proceeds Distribution Agreement • October 17th, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations
This First Amended and Restated Licensing Proceeds Distribution Agreement (hereinafter Amended Agreement’), dated May 16, 2022, (“Restated Effective Date”), is made by and between GRDG Sciences, LLC (“GRDG”), a Florida company with a business address at 234 W. Central Ave., Winter Haven, Florida 33880, and collectively, Global BioLife Inc. (“Global”), Impact BioLife Sciences, Inc., to include Impact Biomedical Inc. (collectively, “Impact’’), each a Nevada corporation with a business address at 701 S. Carson Street, Suite 200, Carson City, Nevada 89701. GRDG, Global and Impact are sometimes referred to herein as the ‘‘Parties” and individually referred to as “PARTY.”
LICENSING PROCEEDS DISTRIBUTION AGREEMENTLicensing Proceeds Distribution Agreement • October 1st, 2024
This First Amended and Restated Licensing Proceeds Distribution Agreement (hereinafter Amended Agreement’), dated May 16, 2022, (“Restated Effective Date”), is made by and between GRDG Sciences, LLC (“GRDG”), a Florida company with a business address at 234 W. Central Ave., Winter Haven, Florida 33880, and collectively, Global BioLife Inc. (“Global”), Impact BioLife Sciences, Inc., to include Impact Biomedical Inc. (collectively, “Impact’’), each a Nevada corporation with a business address at 701 S. Carson Street, Suite 200, Carson City, Nevada 89701. GRDG, Global and Impact are sometimes referred to herein as the ‘‘Parties” and individually referred to as “PARTY.”
